THE ROLE OF CHITOSAN IN AKT KINASE REGULATION ACTIVITY
Journal Title: Progress on Chemistry and Application of Chitin and its Derivatives - Year 2016, Vol 0, Issue
Abstract
A decrease in migration of tumor cells incubated with the investigated chitosan preparations was correlated with a decreased activity of MMP-2 and MMP-9 metalloproteinases, what significantly affected inhibition of tumor cell proliferation. In the investigations of the effects of various chitosan preparations on expression of PCNA, Akt and β-catenin in the normal human 184A1 cells and in breast carcinoma MCF7 cells evaluated at the protein level, significant differences in inhibition of expression of selected genes were noted in the tumor cells. Similarly as in the case of human cells, in mouse cells, the differences in expression of the investigated genes involved solely the Ehrlich carcinoma cells. In the presence of the investigated chitosan preparations, there was observed inhibition of expression of the N-cadherin, β-catenin, Akt and PCNA genes. In case of p21 protein, its level increased, similarly as in the human breast carcinoma cells, what may also be related to phosphorylation of the protein, its capture by the cytosol and prolonging its half-life as compared to the non-phosphorylated form. In case of the normal human 181A1 cells and mouse CRL 1636 cells, no significant alterations were noted in expression of the investigated genes in presence of the employed chitosan preparations.
Authors and Affiliations
Jan Ignacak, Maria Wiśniewska-Wrona, Joanna Dulińska-Litewka, Iwona Pałka, Magdalena Kucharska
NOVEL CHITOSAN DERIVATIVES AS FILMS WITH AN ANTIMICROBIAL EFFECT
This paper presents the results of chitosan acylation with linoleic (LA) and dilinoleic acid (DLA). The chemical structures of the new derivatives with different degrees of substitution of LA and DLA were assessed by Fou...
THE INFLUENCE OF DIFFERENT KINDS OF CHITOSAN ON BIOAVAILABILITY OF ANTI-INFLAMMATORY DRUGS
Chitosan as a dietary supplement has been used in the treatment of obesity due to its capability of binding bioactive compounds. A molecule of a cationic polymer, such as chitosan, may bind acid drugs. The aim of the stu...
INVESTIGATION OF PHYSICOCHEMICAL PROPERTIES OF THE SOLID DISPERSIONS IN THE PRESENCE POLYMERIC CARRIER-CHITOSAN
The BCS class II includes drugs with low solubility and high permeability. Fenofibrate is an example of this class drugs. The aim of the study was to investigate the effect of chitosan on the saturation solubility of fen...
DETERMINATION OF DEGREE OF DEACETYLATION OF CHITOSAN - COMPARISION OF METHODS
Degree of deacetylation (DD) is one of the main parameters characterizing chitosan. The most precise measurements of DD require sophisticated equipment (NMR spectrometer), not available at many laboratories worldwide wor...
THE EFFECT OF VARIOUS TYPES OF CHITOSAN USED AS DIETARY SUPPLEMENTS ON BIOAVAILABILITY OF CERTAIN H-2 HISTAMINE RECEPTOR INHIBITORS
The clinical practice of obesity treatment uses many natural macromolecular compounds which assist in slimming. Chitosan is used in the treatment of obesity due to its lipid, cholesterol, fatty acids, triglycerides and b...